Eppendorf & Science Prize for Neurobiology 2020 Call for Entries!

Pharma |  News | By Ankit Kankar | 0 Comment | 22 Jan, 2020

Eppendorf and the journal Science are now accepting applications for the 2020 Eppendorf & Science Prize for Neurobiology. This annual international research prize of US$25,000 is awar...Read more

Eppendorf SafeCode system enables a safe sample vial tracking

Pharma |  News | By Ankit Kankar | 0 Comment | 22 Jan, 2020

Safe and distinct sample ID is key for successful results in the lab. The new Eppendorf SafeCode system enables a safe sample vial tracking from the bench to the longterm storage in the ULT...Read more

Eppendorf is proudly sponsoring the 2020 International Freezer Challenge

Pharma |  News | By Ankit Kankar | 0 Comment | 22 Jan, 2020

Global warming is a challenge for mankind on earth. Sustainability discussions primarily focus on energy consumption of devices. Even environmentally friendly and energy efficient ultra-low...Read more

TenNor recevies FDA ODD for treating prosthetic joint infections

Pharma |  News | 0 Comment | 22 Jan, 2020

China based TenNor Therapeutics, a clinical-stage, global biopharmaceutical company has received FDA Orphan Drug Designation for TNP-2092 to treat prosthetic joint infections. Medical devi...Read more

Chi-Med to stop pancreatic cancer trial upon early success

Pharma |  News | 0 Comment | 21 Jan, 2020

Hutchison China MediTech has announced that the independent Data Monitoring Committee (“IDMC”) of the Phase III pivotal study of surufatinib in advanced neur...Read more

Propanc Biopharma gets advance overseas finding from BIS Australia

Pharma |  News | 0 Comment | 22 Jan, 2020

Australia based Propanc Biopharma, Inc., a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced that a Certifica...Read more

Zydus gains access to markets in Greater China for CKD treatment

Pharma |  News | 0 Comment | 20 Jan, 2020

Zydus, a leading discovery based global pharmaceutical company based in India has announced that it has entered into a licensing agreement with China Medical System Holdings Limited (CMS) f...Read more

Astellas completes acquisition of Audentes Therapeutics

Pharma |  News | 0 Comment | 20 Jan, 2020

Japan based Astellas Pharma Inc. has successfully completed the previously announced acquisition of Audentes Therapeutics, Inc. (“Audentes”), through a tender offer by its indir...Read more

Astellas invests ¥10B to build new manufacturing facility

Pharma |  News | 0 Comment | 21 Jan, 2020

Japan based Astellas Pharma Inc. has announced that the Third Fermentation Building (provisional name) will be constructed as a new manufacturing facility for active pharmaceutical ingredie...Read more

Novartis Malaysia snags Top Employer Award for 2020

Pharma |  News | 0 Comment | 16 Jan, 2020

Novartis Malaysia, a global leader in the healthcare space has been awarded the Top Employer for 2020.  A highly sought after recognition, this certificate was ...Read more

MOPI to conduct 'International Good Manufacturing Training Program 2020'

Pharma |  News | 0 Comment | 20 Jan, 2020

Malaysian Organisation of Pharmaceutical Industries (MOPI) is organising  'International Good Manufacturing Training Program 2020' endorsed by 'National Pharmaceutical Regul...Read more

Eisai launches anti cancer agent Halaven in China

Pharma |  News | 0 Comment | 17 Jan, 2020

Japan headquartered Eisai Co., Ltd. has announced that it has launched the in-house developed anticancer agent Halaven® (generic name: eribulin mesylate) in China. Halaven is a ha...Read more

Astellas, Adaptimmune to develop CAR-T & TCR T-cell therapies

Pharma |  News | 0 Comment | 17 Jan, 2020

Japan based Astellas Pharma Inc., through its wholly-owned subsidiary Universal Cells, Inc. and Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, have announced that t...Read more

Hanmi Pharma to develop innovative drugs for rare diseases

Pharma |  News | 0 Comment | 16 Jan, 2020

The company, led by President and CEO Se-chang Kwon and co-representative Jong-soo Woo, participated in the 38th J.P. Morgan Healthcare Conference in San Francisco during Jan...Read more

FDF China to boost Chinese pharmaceutical enterprises

Pharma |  News | 0 Comment | 16 Jan, 2020

FDF China, collocated with CPhI China, will be held from June 22-24, 2020 at Shanghai New International Expo Centre (SNIEC). More and more formulation enterprises need to implemen...Read more

ASKA, KinoPharma unite to treat cervical dysplasia

Pharma |  News | 0 Comment | 16 Jan, 2020

ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc., both based in Tokyo, announced that they have entered into an option agreement for an exclusive license for the development and...Read more

A2A, Daewoong to co-develop novel oncology treatments

Pharma |  News | 0 Comment | 16 Jan, 2020

A2A Pharmaceuticals Inc. (A2A) announced an agreement to design and co-develop oncology drug candidates with Daewoong Pharmaceutical Co., Ltd. (Daewoong), a major pharmaceutical company in ...Read more

BioMed X Starts Schizophrenia Research Program with Boehringer Ingelheim

Pharma |  News | 0 Comment | 14 Jan, 2020

BioMed X on 13 Jan 2020 announced the start of a new joint research group in collaboration with Boehringer Ingelheim at the BioMed X Innovation Center in Heidelberg. The aim of th...Read more